Brian T. Powl, Chief Commercial Officer at Kura Oncology, Inc. (KURA), sold 6,414 shares at $8.46 ($54K) on 2026-01-27, disclosed to the SEC on 2026-01-27.
Open-market sale of $54k KURA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.46 | 1,572 | $13K | 24.5% |
| 2 | $8.46 | 4,842 | $41K | 75.5% |
| Total | $8.46 avg | 6,414 | $54K | 100% |
| Filing → |
| KURA | SELL | 2026-05-22 | $110K | — | Filing → |
| KURA | SELL | 2026-05-20 | $3K | — | Filing → |
| KURA | SELL | 2025-11-14 | $199K | — | Filing → |